Intel Stock Plunges 26% as Weak Outlook Sparks Historic Selloff Despite Strong AI Demand

Intel (NASDAQ: INTC) shares plunged as much as 26% on Friday, October 30, putting the semiconductor giant on pace for one of its worst trading days in more than five decades after the company issued a disappointing fourth-quarter forecast and warned that weakness in the personal computer market could extend into 2027.

The sharp decline threatened to erase more than $100 billion in market capitalization, underscoring growing investor concerns about Intel’s turnaround strategy despite stronger-than-expected third-quarter earnings and rapid growth in its data center business.

Intel reported third-quarter revenue of $16.51 billion, up 21% from a year earlier and slightly above Wall Street expectations. Adjusted earnings reached $0.52 per share, exceeding analysts’ estimates of approximately $0.40.

However, the company’s outlook for the final quarter of 2026 disappointed investors. Intel projected revenue between $15 billion and $16 billion, below Wall Street’s expectations of approximately $17.1 billion. Adjusted earnings are expected to reach $0.25 per share, compared with forecasts of roughly $0.43.

The weaker guidance reflects mounting challenges in the global PC market, where rising memory chip prices are increasing production costs and reducing demand for new computers.

Intel now expects worldwide PC shipments to decline approximately 12% in 2026, followed by another 10% decrease in 2027. The company warned that market conditions could remain difficult through at least the first half of next year.

A major factor behind the slowdown is the rapid expansion of artificial intelligence infrastructure. Data center operators are consuming increasing amounts of memory capacity, contributing to higher component prices for consumer laptops and desktop computers.

The trend highlights an emerging divide within the semiconductor industry, as AI-related demand supports certain chipmakers while creating cost pressures across other technology markets.

Intel’s own results illustrate that contrast. Revenue from its data center and AI business jumped 78% year over year to $7.3 billion, supported by strong demand for server processors. Meanwhile, its client computing business generated approximately $8.1 billion in revenue, representing a 5% annual decline.

The company also faces manufacturing challenges following an accident at its semiconductor facility in Israel earlier this month. Intel expects the disruption to reduce fourth-quarter revenue by approximately $300 million.

Chief Executive Officer Lip-Bu Tan, who is leading Intel’s restructuring efforts, acknowledged that rebuilding the company will require several years.

Intel is investing heavily in advanced manufacturing capacity as it works to strengthen its competitive position against semiconductor rivals including Nvidia and Advanced Micro Devices.

The company maintained its 2026 capital expenditure outlook of approximately $20 billion but expects spending to increase substantially in 2027. Management also indicated that Intel does not expect to generate positive free cash flow next year.

For investors, the combination of rising capital expenditures and weaker near-term demand raises questions about how quickly Intel can translate its manufacturing investments into sustainable profitability.

The selloff also weighed on broader semiconductor sentiment, with PC manufacturers and other technology companies facing renewed scrutiny over demand expectations and capital spending.

Despite Friday’s decline, Intel shares remain substantially higher for the year following a powerful rally fueled by optimism surrounding its restructuring and domestic semiconductor manufacturing ambitions.

The latest earnings report demonstrates that strong AI demand alone may not be enough to offset weakness in traditional computing markets.

As Intel enters 2027, investors will be watching for signs of stabilization in PC demand, improvements in manufacturing execution, and evidence that the company’s ambitious turnaround can deliver sustainable financial returns.

Xerox Holdings Corporation (XRX) – Cost Savings Face Mounting Headwinds


Friday, October 30, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Third quarter falls short of expectations. Xerox reported third-quarter revenue of $1.87 billion, largely in line with our estimate, while adjusted EBITDA of $193 million was 12.8% below our forecast. Gross margin of 29.2% was approximately 370 basis points below our estimate, reflecting higher input costs and an unfavorable equipment mix, which more than offset lower operating expenses.

Lexmark savings remain on track. Following our discussions with management, we believe the company remains confident in achieving approximately $100 million of incremental Lexmark integration savings in 2027. Additional opportunities in automation, AI, organizational simplification, and facility consolidation could deliver further benefits, though the timing and magnitude of these savings remain uncertain.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Titan International (TWI) – Still Working Through Headwinds


Friday, October 30, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Quarterly Overview. Inclusive of ITM, which is reported in the 3Q26 financials as discontinued operations, Titan’s revenues of $454 million were above the midpoint of the guidance, while adjusted EBITDA of $28 million was also within the guidance range. Titan’s One Stop Shop strategy continues to enable the Company to deliver solid financial results despite challenging current market conditions.

3Q26 Results. Focused on reported results, which exclude ITM from continuing operations, revenue came in at $335.2 million compared to $357.3 million in the comparable period of 2025. Gross margin was 14.7% of net sales versus 15.7% in 3Q26. Titan reported adjusted EBITDA of $16.4 million, down from $20.3 million last year. Adjusted loss was $0.03/sh compared to adjusted EPS of $0.04 in 3Q25.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

The GEO Group (GEO) – Updated Contract For Northwest ICE Processing Center


Friday, October 30, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

New Contract. The GEO Group entered into a new 10-year contract for the continued provision of support services at the GEO-owned 1,635-bed Northwest ICE Processing Center located in Tacoma, Washington. The new 10-year contract is expected to generate approximately $140 million in annual revenues for GEO and continue through October 27, 2036. We believe this demonstrates the ongoing attractiveness of GEO’s assets for its government partners.

Services. Support services at the Northwest ICE Processing Center are expected to include security, maintenance, and food services, as well as access to recreational amenities, medical care, and transportation services.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Kuya Silver (KUYAF) – Laying the Foundation for Production Growth


Friday, October 30, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Record underground development supports production growth. Kuya Silver reported record underground development at its Bethania silver mine in Peru during the third quarter of 2026, advancing 575 meters and excavating 4,713 tonnes of development material. Management prioritized mine development over near-term production to establish additional working areas and support higher mining rates. Quarterly production totaled 3,401 tonnes of mineralized material, with increased output expected beginning in the fourth quarter and continuing into 2027.

Infrastructure and processing agreements establish a path to higher throughput. An upgraded underground winch system is expected to support the targeted mining rate of 350 tonnes per day (tpd) without completing the planned access ramp. Separately, a strategic agreement with the Camila processing plant secures dedicated capacity of 3,000 tonnes monthly through March 2027, increasing to 4,000 tonnes beginning in April. The agreement supports near-term production growth while allowing Kuya Silver to prioritize construction of its fully permitted 350 tpd Bethania processing plant.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

ACCO Brands (ACCO) – Third Quarter 2026 First Look


Friday, October 30, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Quarterly Overview. ACCO delivered third-quarter sales consistent with management’s outlook, driven by a solid back-to-school season in both North America and Mexico and stabilizing trends in Workspace Solutions. Adjusted EPS included net tariff refunds, with underlying operations in line with outlook. ACCO generated strong cash flows and continued to pay down debt, ending September with a consolidated leverage ratio of 3.6x.

3Q26 Numbers. Third quarter net sales decreased 0.9% to $380.3 million from $383.7 million in 2025, reflecting 4.9% growth from the EPOS acquisition and 0.4% from favorable foreign exchange, which were more than offset by a 6.2% decline in comparable sales. Net income was $11.5 million, or $0.12 per share, compared with $4.0 million, or $0.04 per share, in 2025. Adjusted net income increased to $27.2 million from $19.5 million in 2025, and adjusted earnings per share rose to $0.28 from $0.21 in 2025.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Beam Therapeutics Reports Breakthrough Gene-Editing Results as Patients Show Improved Glucose Control

Beam Therapeutics (NASDAQ: BEAM) has reported encouraging early clinical results from its experimental gene-editing treatment, BEAM-301, demonstrating the potential to significantly improve glucose regulation in patients with glycogen storage disease type Ia (GSDIa), a rare inherited metabolic disorder.

The Cambridge, Massachusetts-based biotechnology company announced results from its ongoing Phase 1/2 clinical trial on October 27, revealing that two patients receiving the higher treatment dose achieved 15 hours of controlled fasting without requiring the frequent starch supplementation typically necessary to manage the disease.

The findings represent an important early milestone for Beam’s base-editing technology, which is designed to correct specific genetic mutations rather than simply manage symptoms.

GSDIa is a rare genetic condition that prevents the liver from properly converting stored glycogen into glucose. Patients can experience dangerously low blood sugar levels and must carefully manage their diets, often consuming uncooked cornstarch throughout the day and night to maintain stable glucose levels.

BEAM-301 is designed to address the underlying genetic cause of the disease by correcting the R83C mutation in the G6PC1 gene. The treatment uses lipid nanoparticles to deliver gene-editing components directly to the liver.

Unlike traditional treatments that require ongoing medication or dietary management, Beam’s approach aims to provide lasting benefits following a single administration.

The initial clinical results included six patients who received BEAM-301, with three treated at a 20-milligram dose and three receiving 40 milligrams.

In the higher-dose group, the median time patients could fast before experiencing low blood sugar increased from 2.5 hours before treatment to 15 hours at the Day 36 assessment.

Two of the three patients in that group reached the study’s maximum controlled fasting duration of 15 hours. Those same two patients eventually eliminated their daily starch supplementation requirements at their latest reported assessments.

Patients also demonstrated improvements in glucose regulation, providing additional evidence that the treatment may help restore the body’s ability to produce glucose naturally.

However, the study remains in its early stages, and the small number of participants limits conclusions about long-term effectiveness.

Safety findings also warrant continued monitoring. Four of the six patients experienced serious treatment-related adverse events, including infusion reactions. The company reported no dose-limiting toxicities, and the serious events had resolved by the data cutoff.

Beam has modified its premedication and infusion procedures as development continues.

Following the results, the company is advancing BEAM-301 into a higher 60-milligram dose cohort and plans to engage with the U.S. Food and Drug Administration regarding a potential regulatory pathway.

For investors, the announcement offers early clinical evidence supporting Beam’s precision genetic medicine platform. Successful development could establish base editing as a potential treatment strategy for certain inherited metabolic diseases.

The technology differs from conventional gene-editing approaches because it can make targeted changes to individual DNA bases without requiring double-strand DNA breaks.

That distinction could have broader implications for biotechnology companies developing therapies for diseases caused by specific genetic mutations.

Nevertheless, significant clinical and regulatory hurdles remain. Larger studies, longer patient follow-up, and additional safety evaluations will be necessary before BEAM-301 can be considered for approval.

Beam’s latest results highlight the growing potential of next-generation gene-editing treatments while illustrating the substantial development risks associated with bringing innovative therapies to market.

Release – ACCO Brands Reports Third Quarter Results

ACCO Brands Logo

Research News and Market Data on ACCO

10/29/2026

  • Reported net sales of $380 million, in line with outlook
  • Diluted EPS of $0.12 and adjusted diluted EPS of $0.28, both include $0.11 per share in net tariff refunds
  • Closed on the acquisition of Trust on October 1, 2026
  • Raises full-year 2026 outlook to reflect tariff refunds and the acquisition

LAKE ZURICH, Ill.–(BUSINESS WIRE)– ACCO Brands Corporation (NYSE: ACCO) today reported financial results for the third quarter ended September 30, 2026.

“We delivered third quarter sales consistent with our outlook, driven by a solid back-to-school season in both North America and Mexico and stabilizing trends in Workspace Solutions. Adjusted EPS included net tariff refunds, with underlying operations in line with outlook. We generated strong cash flows and continue to pay down debt, ending September with a consolidated leverage ratio of 3.6x,” stated ACCO Brands’ President and Chief Executive Officer, Tom Tedford.

“Technology peripherals remain our strongest long-term growth opportunity, and we closed on the acquisition of Trust, which will expand our tech peripheral portfolio to approach $500 million of pro forma annual sales. With Kensington, PowerA, EPOS and Trust, we now have a scaled platform across consumer and enterprise channels in large growth categories. Our focus is integrating these brands and delivering synergy opportunities,” added Mr. Tedford.

Third Quarter Tariff Refund Impact

During the third quarter of 2026, net tariff refunds benefited consolidated operating income by $15.1 million. This resulted in a net per share benefit of $0.11 to our diluted earnings per share and 400 basis points of improvement in the consolidated adjusted operating margin in the quarter.

Third Quarter Results

Third quarter net sales decreased 0.9 percent to $380.3 million from $383.7 million in 2025. This decrease reflects 4.9 percent growth from the EPOS acquisition and 0.4 percent from favorable foreign exchange, which were more than offset by a 6.2 percent decline in comparable sales. Technology peripherals experienced softness due to global industry-wide challenges. Our overall back-to-school season was positive, with more sales being recognized in the second quarter.

Operating income was $30.3 million, compared with $26.0 million in 2025. Current-year operating income included one-time charges of $5.9 million, compared with $1.5 million in the prior year. Adjusted operating income increased to $47.8 million, up from $39.2 million in 2025, reflecting cost savings, partly offset by lower mix. Current-year operating income and adjusted operating income include $15.1 million in net tariff refunds.

Net income was $11.5 million, or $0.12 per share, compared with $4.0 million, or $0.04 per share, in 2025. The improvement in net income reflects items noted above in operating income and adjusted operating income, plus differences in discrete tax items. Adjusted net income increased to $27.2 million, from $19.5 million in 2025, and adjusted earnings per share rose to $0.28 from $0.21 in 2025.

Business Segment Results

ACCO Brands Americas – Third quarter segment net sales of $219.8 million decreased 3.4 percent from $227.6 million in the prior year. Growth from the EPOS acquisition of 2.0 percent and favorable foreign currency of 1.0 percent was more than offset by a 6.4 percent comparable sales decline. Lower demand for technology peripherals was offset by growth in Latin America.

Third quarter operating income was $25.4 million, compared with $24.7 million a year earlier, with larger non-recurring items this year. Adjusted operating income increased to $38.1 million, from $32.7 million in the prior year. The increase in both operating and adjusted operating income reflects net tariff refunds, partly offset by lower mix and volume.

ACCO Brands International – Third quarter segment net sales were $160.5 million, an increase of 2.8 percent from $156.1 million in the prior year. The EPOS acquisition increased sales by 9.2 percent and unfavorable foreign exchange reduced sales 0.4 percent. Comparable sales were down 6.0 percent year-over-year, reflecting lower demand for technology peripherals and softness in Australia.

Third quarter operating income was $12.4 million, compared with operating income of $10.5 million in the prior year. Adjusted operating income was $17.0 million, compared with $15.9 million in the prior year. The increase in both reflects pricing and cost savings, partly offset by lower mix.

Nine Month Results

Net sales of $1,139.1 million increased 3.9 percent from $1,095.9 million in 2025. The EPOS acquisition increased sales by $56.4 million, or 5.1 percent, and favorable foreign exchange increased sales by $27.6 million, or 2.5 percent. Comparable sales decreased 3.7 percent due to industry-wide trends in technology peripherals, partially mitigated by stronger demand for learning and creative categories in the Americas segment. Globally, workspace solutions trends have moderated versus the prior year.

Operating income was $50.2 million compared with $52.3 million in 2025. Current-year operating income included restructuring and other non-recurring items totaling $23.2 million, compared with $13.2 million in the prior year. Prior-year operating income benefited from a gain on sale of assets of $6.9 million. Adjusted operating income increased to $107.6 million from $93.2 million in 2025. Current-year operating income and adjusted operating income include $15.1 million of net tariff refunds.

Net income was $45.0 million, or $0.47 per share, compared with a net income of $20.0 million, or $0.21 per share, in 2025. Nine-month net income benefited from a $33.8 million bargain purchase gain related to the preliminary purchase price allocation, partially offset by costs for the EPOS acquisition, and reflects items noted above in operating income. Prior-year net income was positively impacted by discrete tax items, notably the Company’s settlement of the outstanding tax assessments in Brazil. Adjusted net income was $56.4 million compared with $43.3 million in 2025, and adjusted earnings per share were $0.59 per share compared with $0.46 per share in 2025, reflecting items noted above in operating income and adjusted operating income.

Cash Flow, Debt and Dividend

Year to date, free cash flow was $89.0 million including $21.3 million of tariff refunds, compared with $25.8 million in the prior year. The cash balance of $174.7 million at quarter end included cash held for the acquisition of Trust, which closed on October 1. The Company’s consolidated leverage ratio was 3.6x as of September 30, 2026.

Year to date, the Company has paid dividends of $20.8 million.

On October 23, 2026, ACCO Brands announced that its board of directors declared a regular quarterly cash dividend of $0.075 per share, payable on December 9, 2026 to stockholders of record at the close of business on November 20, 2026.

Full Year 2026 Outlook

For the full year, the Company expects reported sales to increase 4.0 percent to 6.0 percent, updated to include one quarter of expected sales from the acquired Trust business. Full-year adjusted EPS is expected to be $0.98 to $1.02 inclusive of $0.12 from the tariff refund. The Company expects 2026 free cash flow of approximately $100 million and the consolidated leverage ratio of approximately 3.5x at year-end.

Webcast

At 8:30 a.m. ET on October 30, 2026, ACCO Brands Corporation will host a conference call to discuss the Company’s third quarter 2026 results. The call will be broadcast live via webcast. The webcast can be accessed through the Investor Relations section of www.accobrands.com. The webcast will be in listen-only mode and will be available for replay following the event.

About ACCO Brands Corporation

ACCO Brands is a global leader in branded technology peripherals, workspace solutions, education and creative products that enable people to work with more productivity, learn with more confidence and play with more enjoyment. We develop, nurture and acquire a portfolio of distinct, innovative and widely recognized brands, including EPOS®, Five Star®, Kensington®, Leitz®, Mead®, PowerA®, Tilibra®, Trust® and many others. More information about ACCO Brands Corporation (NYSE: ACCO) can be found at www.accobrands.com.

Non-GAAP Financial Measures

In addition to financial results reported in accordance with generally accepted accounting principles (GAAP), we have provided certain non-GAAP financial information in this earnings release to aid investors in understanding the Company’s performance. Each non-GAAP financial measure is defined and reconciled to its most directly comparable GAAP financial measure in the “About Non-GAAP Financial Measures” section of this earnings release.

Forward-Looking Statements

Statements contained herein, other than statements of historical fact, particularly those anticipating future financial performance, business prospects, growth, strategies, business operations and similar matters, results of operations, liquidity and financial condition, and those relating to cost reductions and anticipated pre-tax savings and restructuring costs are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management based on information available to us at the time such statements are made. These statements, which are generally identifiable by the use of the words “will,” “believe,” “expect,” “intend,” “anticipate,” “estimate,” “forecast,” “future”, “project,” “plan,” and similar expressions, are subject to certain risks and uncertainties, are made as of the date hereof, and we undertake no duty or obligation to update them. Forward-looking statements are subject to the occurrence of events outside the Company’s control and actual results, and the timing of events may differ materially from those suggested or implied by such forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. Investors and others are cautioned not to place undue reliance on forward-looking statements when deciding whether to buy, sell or hold the Company’s securities.

Our outlook is based on certain assumptions which we believe to be reasonable under the circumstances. These include, without limitation, assumptions regarding consumer demand, tariffs, global geopolitical and economic uncertainties, and fluctuations in foreign currency exchange rates; and the other factors described below.

Among the factors that could cause our actual results to differ materially from our forward-looking statements are: changes in trade policy and regulations, including changes in trade agreements and the imposition of tariffs, the timing and recoverability of tariff refund claims, and the resulting consequences; global political and economic uncertainties; a limited number of large customers account for a significant percentage of our sales; sales of our products are affected by general economic and business conditions globally and in the countries in which we operate; risks associated with foreign currency exchange rate fluctuations; challenges related to the highly competitive business environment in which we operate; our ability to develop and market innovative products that meet consumer demands and to expand into new and adjacent product categories; our ability to successfully expand our business in emerging markets and the exposure to greater financial, operational, regulatory, compliance and other risks in such markets; the continued decline in the use of certain of our products; risks associated with seasonality, the sufficiency of investment returns on pension assets, risks related to actuarial assumptions, changes in government regulations and changes in the unfunded liabilities of a multi-employer pension plan; any impairment of our intangible assets; our ability to secure, protect and maintain our intellectual property rights, and our ability to license rights and receive certifications from equipment and software businesses to support our technology accessories business; the introduction by third parties of new and successful gaming consoles; our ability to grow profitably through acquisitions, and successfully integrate them; our ability to successfully execute our multi-year restructuring and cost savings program and realize the anticipated benefits; continued disruptions in the global supply chain; risks associated with inflation and other changes in the cost or availability of raw materials, transportation, labor, and other necessary supplies and services and the cost of finished goods; risks associated with outsourcing production of certain of our products, information technology systems and other administrative functions; the failure, inadequacy or interruption of our information technology systems or their supporting infrastructure; risks associated with a cybersecurity incident or information security breach, including that related to a disclosure of personally identifiable information; risks associated with the use by us and other suppliers of artificial intelligence, risks associated with our indebtedness, including limitations imposed by restrictive covenants, our debt service obligations, and our ability to comply with financial ratios and tests; a change in or discontinuance of our stock repurchase program or the payment of dividends; product liability claims, recalls or regulatory actions; the impact of litigation or other legal proceedings; the impact of additional tax liabilities stemming from our global operations and changes in tax laws, regulations and tax rates; our failure to comply with applicable laws, rules and regulations and self-regulatory requirements, the costs of compliance and the impact of changes in such laws; our ability to attract and retain qualified personnel; the volatility of our stock price; risks associated with circumstances outside our control, including those caused by telecommunication failures, labor strikes, power and/or water shortages, public health crises, such as the occurrence of contagious diseases, severe weather events, war, terrorism and other geopolitical incidents; and other risks and uncertainties described in “Part I, Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, and in other reports we file with the Securities and Exchange Commission.

View full release here.

For further information:

Christopher McGinnis
Investor Relations
(847) 796-4320

Kori Reed
Media Relations
(224) 501-0406Source: ACCO Brands Corporation

Release – Newsmax to Report Third Quarter 2026 Financial Results

Newsmax logo image

Research News and Market Data on NMAX

October 29, 2026

BOCA RATON, FL / ACCESS Newswire / October 29, 2026 / Newsmax Inc. (NYSE:NMAX) (“Newsmax” or the “Company”) today announced that the Company will report financial results for the third quarter ended September 30, 2026 on Thursday, November 12, 2026, after the U.S. stock market closes.

Management will host a conference call at 4:30 PM ET the same day to discuss the results. The live webcast and replay will be available on the Newsmax Investor Relations website at ir.newsmax.com.

About Newsmax

Newsmax Inc. is listed on the NYSE (NMAX) and operates, through Newsmax Broadcasting LLC, one of the nation’s leading news outlets, the Newsmax channel. The fourth highest-rated network is carried on all major pay TV providers. Newsmax’s media properties reach more than 50 million Americans regularly through Newsmax TV, the Newsmax App, its popular website Newsmax.com, and publications such as Newsmax Magazine. Through its social media accounts, Newsmax reaches over 26 million combined followers. Reuters Institute says Newsmax is one of the top U.S. news brands and Forbes has called Newsmax “a news powerhouse.”

For more information, please visit Investor Relations | Newsmax Inc.

Investor Contacts

Newsmax Investor Relations
[email protected]

SOURCE: Newsmax Inc.

View the original press release on ACCESS Newswire

Release – The ONE Group Hospitality, Inc. to Host Third Quarter 2026 Earnings Conference Call and Webcast at 4:30 PM ET on November 4, 2026

The ONE Group Hospitality, Inc.

Research News and Market Data on STKS

Download as PDFOctober 29, 2026

DENVER–(BUSINESS WIRE)– The ONE Group Hospitality, Inc. (“The ONE Group” or the “Company”) (Nasdaq: STKS) today announced that Emanuel “Manny” Hilario, President and Chief Executive Officer, and Nicole Thaung, Chief Financial Officer, will host a conference call and webcast to discuss third quarter 2026 financial results on Wednesday, November 4, 2026, at 4:30 PM ET. A press release containing the third quarter 2026 financial results will be issued after market close that same afternoon.

The conference call can be accessed live over the phone by dialing 201-389-0908. A replay will be available after the call and can be accessed by dialing 412-317-6671; the passcode is 13762363. The replay will be available until Wednesday, November 18, 2026.

The webcast can be accessed from the Investor Relations tab of The ONE Group’s website at http://www.togrp.com/ under “News / Events”.

About The ONE Group

The ONE Group Hospitality, Inc. (Nasdaq: STKS) is an international restaurant company that develops and operates upscale and polished casual, high-energy restaurants and lounges and provides hospitality management services for hotels, casinos and other high-end venues both in the U.S. and internationally. The ONE Group is recognized as one of “America’s Greatest Companies” (Newsweek, 2025), and Benihana is honored as one of “America’s Best Brands for Value” (Forbes, 2025). The ONE Group’s focus is to be the global leader in Vibe Dining, and its primary restaurant brands and operations are:

  • STK, a modern twist on the American steakhouse concept with restaurants in major metropolitan cities in the U.S., Europe and the Middle East, featuring premium steaks, seafood and specialty cocktails in an energetic upscale atmosphere.
  • Benihana, an interactive dining destination with highly skilled chefs preparing food right in front of guests and served in an energetic atmosphere alongside fresh sushi and innovative cocktails. The Company franchises Benihanas in the U.S., Caribbean, Central America, and South America.
  • Samurai, an interactive dining experience located in sunny Miami, FL, provides a distinctive dining experience where skilled personal chefs masterfully perform the ancient art of teppanyaki right before your eyes.
  • Kona Grill, a polished casual, bar-centric Grill concept with restaurants in the U.S., featuring American favorites, award-winning sushi, and specialty cocktails in an upscale casual atmosphere.
  • Salt Water Social is your gateway to the seven seas, featuring an array of signature and unique fresh seafood items, complemented by the highest quality beef dishes and elegant, delicious cocktails.
  • Benihana Express, a small footprint casual concept showcasing the best of Benihana but without teppanyaki tables or bar.
  • RA, a Japanese fusion cuisine concept that offers a fun-filled, bar-forward, upbeat, and vibrant dining atmosphere with restaurants in the U.S. anchored by creative sushi, inventive drinks, and outstanding service.
  • ONE Hospitality, The ONE Group’s food and beverage hospitality services business develops, manages and operates premier restaurants and turnkey food and beverage services within high-end hotels and casinos currently operating venues in the U.S. and Europe.

Additional information about The ONE Group can be found at www.togrp.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261029967326/en/

Investors:
ICR
Michelle Michalski or Raphael Gross
[email protected]

Media:
ICR
Judy Lee
[email protected]

Source: The ONE Group Hospitality, Inc.

Released October 29, 2026

Release – Snail Games USA Launches Dead Party, Expanding Its Cooperative Multiplayer Portfolio

Snail, Inc logo

Research News and Market Data on SNAL

October 29, 2026 at 1:05 PM EDT

PDF Version

CULVER CITY, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, today launched Dead Party, a cooperative party-action game developed by Radiation Blue and published by Snail Games USA, now available on Steam.

Dead Party challenges groups of up to four players to work together against waves of the undead, combining strategic base defense and tactical decision-making with fast-paced, music-driven combat. Built around teamwork, coordination, experimentation, and replayable encounters, the game delivers a shared social gaming experience with arcade-style action. Timed to coincide with Halloween, the launch aims to attract additional seasonal flow while adding a distinctive multiplayer title to Snail Games USA’s growing portfolio of interactive entertainment properties.

Dead Party Gameplay Highlights

  • Four-player cooperative gameplay: Players team up to defend their positions, coordinate strategies, and survive increasingly dangerous zombie encounters.
  • Strategic base defense: Resource gathering, barricade construction, and trap placement let players adapt their defenses to evolving threats.
  • Music-driven combat: Guitar-based abilities and music-themed mechanics introduce an unconventional twist to zombie combat.
  • Multiple gameplay modes: Story Mode and a customizable Arcade Mode offer different ways to experience the game and return to its challenges.
  • Built for sharing: Cooperative mechanics and unpredictable encounters create opportunities for shared experiences, community participation, and creator-led discovery.

This release builds on Snail Games’ track record with cooperative and social multiplayer titles, including West Hunt, which sold over 100,000 units before its 1.0 launch and currently holds a “Very Positive” rating across more than 1,500 Steam reviews. These games offer a complementary approach to audience engagement, with shared challenges and memorable player interactions supporting community development and streaming visibility. With accessible mechanics and distinctive gameplay systems designed to bring friends together, Dead Party adds to that lineup as Snail Games USA continues to expand across genres and strengthen its publishing portfolio through differentiated gaming experiences.

Dead Party is available now on Steam.

Creators interested in collaborations can contact [email protected]

About Snail, Inc.
Snail, Inc. (Nasdaq: SNAL) is a leading, global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PCs, and mobile devices. For more information, please visit: https://snail.com/.

Forward-Looking Statements
This press release contains statements that constitute forward-looking statements. Many of the forward-looking statements contained in this press release can be identified by the use of forward-looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “may,” “predict,” “continue,” “estimate” and “potential,” or the negative of these terms or other similar expressions. These forward-looking statements include information about possible or assumed future results of Snail Games’ business, financial condition, results of operations, liquidity, plans and objectives. Forward-looking statements appear in a number of places in this press release and include, but are not limited to, statements regarding Dead Party representing another opportunity to engage players through experiences designed to bring friends together; Dead Party’s cooperative mechanics and unpredictable encounters creating opportunities for shared experiences, community participation, and creator-led discovery; social and cooperative games offering a complementary approach to audience engagement and creating opportunities for community development and streaming visibility; Snail Games continuing to expand across genres and player preferences and strengthening its publishing portfolio through differentiated gaming experiences and opportunities to cultivate audience engagement; and assumptions underlying any of the foregoing. Further information on risks, uncertainties and other factors that could affect Snail Games’ financial results and business include Snail Games’ ability to strengthen its gaming portfolio’s visibility; Snail Games’ ability to expand and grow its publishing portfolio and increase its revenue; Snail Games’ ability to retain its key employees or maintain its Nasdaq listing; and the risks that are included in its filings with the Securities and Exchange Commission (the “SEC”) from time to time, including its annual reports on Form 10-K and quarterly reports on Form 10-Q filed, or to be filed, with the SEC. You should not rely on these forward-looking statements, as actual outcomes and results may differ materially from those expressed or implied in the forward-looking statements as a result of such risks and uncertainties. All forward-looking statements in this press release are based on management’s beliefs and assumptions and on information currently available to Snail Games, and Snail Games does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

Investor Contact:
John Yi and Steven Shinmachi
Gateway Group, Inc.
949-574-3860
[email protected]

Release – NeuroSense to Present Integrated Clinical and Biomarker Evidence Shaping PrimeC’s Phase 3 Development at NEALS 2026

Research News and Market Data on NRSN

Presentation will highlight how findings from the PARADIGM program are informing the clinical development strategy for PARAGON

CAMBRIDGE, Mass., Oct. 29, 2026 /PRNewswire/ — NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) (“NeuroSense” or the “Company”), a biotechnology company developing treatments for neurodegenerative diseases, today announced that its clinical and biomarker findings informing the next phase of PrimeC’s development will be presented at the 2026 Annual Meeting of the Northeast Amyotrophic Lateral Sclerosis (NEALS) Consortium in Clearwater, Florida.

The presentation, titled “From PARADIGM to PARAGON: Converging Clinical and Biomarker Findings Informing Phase 3 Development of PrimeC,” is scheduled for Friday, October 30, at 11:25 a.m. Eastern Time.

The presentation will highlight how clinical and biomarker findings from the PARADIGM Phase 2b program are shaping PARAGON, NeuroSense’s planned Phase 3 study of PrimeC in ALS, supporting a rigorous and more efficient approach to clinical development.

It will be co-presented by Prof. Merit Cudkowicz, MD, MSc, Director of the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Julieanne Dorn Professor of Neurology at Harvard Medical School, and Dr. Shiran Zimri, PhD, Vice President of R&D and Country Lead, Canada, at NeuroSense.

About NeuroSense

NeuroSense Therapeutics is a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease. The Company’s lead product candidate, PrimeC, is a novel oral therapy designed to target multiple key biological pathways underlying disease progression, including neuroinflammation, oxidative stress and dysregulated iron metabolism.

NeuroSense has recently completed analysis of long-term follow-up data from its Phase 2b PARADIGM study in ALS, with results published in JAMA Neurology showing slower functional decline in participants who received PrimeC from study start than in those who initially received placebo. The Company also reported changes across multiple biomarkers associated with ALS, including microRNAs, consistent with PrimeC’s multi-target mechanism of action.

NeuroSense has received clearance from the U.S. Food and Drug Administration (FDA) to initiate its pivotal Phase 3 clinical trial (PARAGON) in ALS, to be conducted primarily in the United States. The Company is working with FDA on an optimized design for the study.

For additional information, we invite you to visit our website and follow us on LinkedIn, YouTube and X. Information that may be important to investors may be routinely posted on our website and these social media channels.

About PrimeC

PrimeC, NeuroSense’s lead drug candidate, is a novel extended-release oral formulation composed of a unique fixed-dose combination of two FDA-approved drugs: ciprofloxacin and celecoxib. PrimeC is designed to target several key mechanisms that contribute to neuron degeneration, inflammation, iron accumulation and impaired ribonucleic acid (“RNA”) regulation, with the potential to inhibit disease progression.

About ALS

Amyotrophic lateral sclerosis (“ALS”) is an incurable neurodegenerative disease that causes progressive paralysis and, typically, death within 3 years of symptoms onset. Every year, more than 5,000 people are diagnosed with ALS in the U.S. alone, with an annual disease burden of $1 billion. The number of people living with ALS is expected to grow by 24% by 2040 in the U.S. and EU.

Forward-Looking Statements

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on NeuroSense Therapeutics’ current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict and include statements regarding the Company’s development program, including for ALS and TBI, the potential issuance, scope and duration of patent protection arising from the Company’s patent application, including expected protection through 2047, subject to any extensions, the potential of PrimeC to treat TBI and related central nervous system injuries, the potential expansion of PrimeC beyond ALS and its potential commercial benefits and long-term value. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. The future events and trends may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. These risks include the risk that the patent application will not result in an issued patent or that any patent granted will not provide the Company with the anticipated scope or duration of protection or will be challenged, invalidated or unenforceable; the risk that PrimeC will not demonstrate safety or efficacy in TBI or related conditions; the potential for delay in the timing of the Phase 3 clinical trial (PARAGON) in ALS; the risk that the Company will not be able to obtain financing on acceptable terms, or at all; the risk that the Company will not regain and maintain compliance with the Nasdaq listing requirements; the risk that non-dilutive grant funding for the PARAGON trial will not be awarded or will be delayed; uncertainty regarding outcomes and the timing of current and future clinical trials; the risk that PrimeC will not advance towards later-stage development; timing for reporting data, including from the study of PrimeC in Alzheimer’s disease; that the study will not be successful; and other risks and uncertainties set forth in NeuroSense’s filings with the Securities and Exchange Commission (SEC). You should not rely on these statements as representing our views in the future. More information about the risks and uncertainties affecting NeuroSense is contained under the heading “Risk Factors” in the Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 31, 2026 and NeuroSense’s subsequent filings with the SEC. Forward-looking statements contained in this announcement are made as of this date, and NeuroSense undertakes no duty to update such information except as required under applicable law.

SOURCE NeuroSense

For further information: For further information: Email: [email protected] | Tel: +972-(0)9-799-6183

Release – Alliance Entertainment to Host First Quarter Fiscal Year 2027 Results Conference Call on November 12 at 4:30 p.m. Eastern Time

Research News and Market Data on AENT

PLANTATION, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) — Alliance Entertainment Holding Corporation (Nasdaq: AENT), a scaled entertainment commerce and collectibles platform serving content owners, brands, retailers and fans across music, movies, gaming, licensed merchandise and collectibles, with proprietary brands, authentication technology and reach across more than 35,000 retail and e-commerce storefronts, will hold a conference call on Thursday, November 12, at 4:30 p.m. Eastern Time to discuss its results for the first quarter of fiscal year 2027 ended September 30, 2026. A press release detailing these results will be issued prior to the call.

Alliance Entertainment Chief Executive Officer Jeff Walker, Chief Financial Officer Amanda Gnecco, and Executive Chairman Bruce Ogilvie will host the conference call, which will be followed by a question-and-answer session. A presentation will accompany the call and can be viewed during the webcast or accessed via the investor relations section of the Company’s website here.

To access the call, please use the following information:

Date:Thursday, November 12, 2026
Time:4:30 p.m. Eastern Time, 1:30 p.m. Pacific Time
Toll-free dial-in number:1-844-825-9789
International dial-in number:1-412-317-5180
Conference ID:10213070

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact RedChip Companies at 1-407-644-4256.

The conference call will be broadcast live and available for replay at https://viavid.webcasts.com/starthere.jsp?ei=1781348&tp_key=9221210ff0 and via the investor relations section of the Company’s website here.

A telephone replay of the call will be available approximately three hours after the call concludes and can be accessed through December 12, 2026, using the following information:

Toll-free replay number:1-844-512-2921
International replay number:1-412-317-6671
Replay ID:10213070


About Alliance Entertainment

Alliance Entertainment (NASDAQ: AENT) is a premier distributor and fulfillment partner for the entertainment and pop culture collectibles industry. With more than 340,000 unique in-stock SKUs – including over 57,300 exclusive titles across compact discs, vinyl LPs, DVDs, Blu-rays, and video games – Alliance offers the largest selection of physical media in the market. Our vast catalog also includes licensed merchandise, toys, retro gaming products, and collectibles, serving over 35,000 retail locations and powering e-commerce fulfillment for leading retailers. Alliance also owns and operates proprietary collectibles brands, including Handmade by Robots™, a stylized vinyl figure line featuring licensed characters from leading entertainment franchises, and Alliance Authentic™, a premium platform for authentic, certified, and individually numbered entertainment collectibles. In addition, Alliance operates Endstate Authentic, a dedicated NFC-enabled authentication and digital product identity platform supporting authenticated collectibles, resale, and brand protection. Leveraging decades of operational expertise, exclusive sourcing relationships, and a capital-light, scalable infrastructure, Alliance connects fans and collectors to the products, franchises, and experiences they value across formats and generations. For more information, visit www.aent.com.

For investor inquiries, please contact:

Dave Gentry
RedChip Companies, Inc.
1-800-REDCHIP (733-2447)
1-407-644-4256
[email protected]